MedTrace Logo

Pseudophakic Cystoid Macular Lesions After Uncomplicated Standard Phacoemulsification

NCT03106402 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 316

Last updated 2017-04-10

No results posted yet for this study

Summary

To assess the incidence, risk factors and clinical courses of cystic macular lesions (CMLs) after uncomplicated phacoemulsification and evaluate the efficacy of topical NSAIDs on the prevention of pseudophakic cystic macular lesions

Conditions

  • Pseudophakic Cystoid Macular Lesions After Uncomplicated Standard Phacoemulsification

Interventions

DRUG

topical bromfenac sodium hydrate

Sponsors & Collaborators

  • Kyungpook National University Hospital

    lead OTHER

Principal Investigators

  • Hong Kyun Kim, M.D. PhD · Kyungpook National University Hospital

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-10-01
Primary Completion
2015-06-30
Completion
2015-07-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03106402 on ClinicalTrials.gov